SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-056288
Filing Date
2018-10-31
Accepted
2018-10-31 07:32:35
Documents
3
Period of Report
2018-10-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv505580_8k.htm 8-K 20190
2 EXHIBIT 99.1 tv505580_ex99-1.htm EX-99.1 97792
3 GRAPHIC logo.jpg GRAPHIC 2324
  Complete submission text file 0001144204-18-056288.txt   122530
Mailing Address 10 HUDSON YARDS, 37TH FLOOR New York NY 10001
Business Address 10 HUDSON YARDS, 37TH FLOOR NEW YORK NY 10001 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Filer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35668 | Film No.: 181148716
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1